These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 8016392

  • 1. The production of experimental cholecystitis by endotoxin.
    Kaminski DL, Feinstein WK, Deshpande YG.
    Prostaglandins; 1994 Mar; 47(3):233-45. PubMed ID: 8016392
    [Abstract] [Full Text] [Related]

  • 2. The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor.
    Kaminski DL, Andrus CH, German D, Deshpande YG.
    Ann Surg; 1990 Oct; 212(4):455-61. PubMed ID: 2171443
    [Abstract] [Full Text] [Related]

  • 3. Studies on the etiology of acute acalculous cholecystitis: the effect of lipopolysaccharide on human gallbladder mucosal cells.
    Kaminski DL, Amir G, Deshpande YG, Beck D, Li AP.
    Prostaglandins; 1994 Apr; 47(4):319-30. PubMed ID: 8041874
    [Abstract] [Full Text] [Related]

  • 4. Effect of bradykinin on feline gallbladder water transport and prostanoid formation.
    German D, Barcia J, Brems J, Merenda G, Kaminski DL.
    Dig Dis Sci; 1989 Nov; 34(11):1770-6. PubMed ID: 2582988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostanoids and leukotrienes in experimental feline cholecystitis.
    Kaminski DL, Daneshmand H, Dean P, Deshpande YG.
    Hepatology; 1990 Jun; 11(6):1003-9. PubMed ID: 2365279
    [Abstract] [Full Text] [Related]

  • 7. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F, Whittle BJ, Moncada S.
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-1 mediates guinea pig gallbladder inflammation in vivo.
    Prystowsky JB, Rege RV.
    J Surg Res; 1997 Aug; 71(2):123-6. PubMed ID: 9299279
    [Abstract] [Full Text] [Related]

  • 11. Gallbladder mucosal protein secretion during development of experimental cholecystitis.
    Kaminski DL, Deshpande YG, Li A, Dysart F, Nag M.
    Dig Dis Sci; 1995 May; 40(5):1157-64. PubMed ID: 7729280
    [Abstract] [Full Text] [Related]

  • 12. Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures.
    Myers SI, Turnage R, Kadesky K, Bartula L, Riva A, Kalley-Taylor B.
    Prostaglandins; 1995 Jul; 50(1):19-32. PubMed ID: 8588069
    [Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin.
    Ferguson-Chanowitz KM, Katocs AS, Pickett WC, Kaplan JB, Sass PM, Oronsky AL, Kerwar SS.
    J Infect Dis; 1990 Nov; 162(5):1081-6. PubMed ID: 2230235
    [Abstract] [Full Text] [Related]

  • 14. Evidence for a colonic PAF receptor.
    Longo WE, Carter JD, Chandel B, Niehoff M, Standeven J, Deshpande Y, Vernava AM, Polites G, Kulkarni AD, Kaminski DL.
    J Surg Res; 1995 Jan; 58(1):12-8. PubMed ID: 7830400
    [Abstract] [Full Text] [Related]

  • 15. The effect of capsaicin on gallbladder fluid absorption.
    Fitzgerald S, Deshpande YG, Nguyen HQ, Kaminski DL.
    Hepatology; 1991 Oct; 14(4 Pt 1):660-4. PubMed ID: 1916667
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
    Albert DH, Magoc TJ, Tapang P, Luo G, Morgan DW, Curtin M, Sheppard GS, Xu L, Heyman HR, Davidsen SK, Summers JB, Carter GW.
    Eur J Pharmacol; 1997 Apr 23; 325(1):69-80. PubMed ID: 9151941
    [Abstract] [Full Text] [Related]

  • 17. The effect of SRI 63-675, a competitive platelet-activating factor receptor-antagonist, in the generalized Shwartzman reaction.
    Gans RO, DiPirro JC, Ueda Y, Niesen N, Lee KH, Brentjens JR.
    J Lipid Mediat Cell Signal; 1994 Sep 23; 10(3):229-42. PubMed ID: 7812674
    [Abstract] [Full Text] [Related]

  • 18. Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance.
    Jacob SP, Lakshmikanth CL, Chaithra VH, Kumari TR, Chen CH, McIntyre TM, Marathe GK.
    PLoS One; 2016 Sep 23; 11(4):e0153282. PubMed ID: 27064683
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J, Harada K, Kimura A, Kobayashi S, Murakami M, Yoshimura T, Yamada K, Asano O, Katayama K, Yamatsu I.
    Arzneimittelforschung; 1991 Jul 23; 41(7):719-24. PubMed ID: 1663352
    [Abstract] [Full Text] [Related]

  • 20. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.
    Salzer WL, McCall CE.
    J Clin Invest; 1990 Apr 23; 85(4):1135-43. PubMed ID: 2318970
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.